Plan affordability and prescription drug access are strategic imperatives for our clients and for Cigna. Our low net drug cost approach removes or manages certain high-priced, low-value drugs where clinically appropriate alternatives are available – regardless of drug company incentives or rebates. For January 2023, we will make a number of changes to achieve better drug affordability and improved pharmacy plan performance with low impact to customers.
